Safety, Efficacy and Pharmacokinetics of Crisaborole Ointment 2% in Infants Age Three to Less Than 24 Months with Mild-to-Moderate Atopic Dermatitis

08/09/2020 6 min Temporada 1 Episodio 3

Listen "Safety, Efficacy and Pharmacokinetics of Crisaborole Ointment 2% in Infants Age Three to Less Than 24 Months with Mild-to-Moderate Atopic Dermatitis"

Episode Synopsis

This poster was presented by Dr. Schlessinger and colleagues at the 2020 American Academy of Dermatology virtual annual meeting.
This overview is provided by Dr. Steve Feldman.

More episodes of the podcast Research Developments in Atopic Dermatitis